Case presentation
=================

A 53-year-old male was admitted to a hospital with 15 days history of dyspnoea, weakness and oliguria, and muscle pain. His medical history included pulmonary thromboembolic, hypertension and cardiac arrhythmia. He had undergone total thyroidectomy for papillary thyroid cancer two years ago. His medication consisted of metoprolol, enoxaparin and [l-]{.smallcaps}thyroxine with no use in the past 4 weeks. Physical examination revealed dry and pale skin and slow speech. His pulse rate was 55 beats/minute and blood pressure was 130/90 mm Hg. Electrocardiography has shown bigemine ventricular extra systole. Laboratory investigations showed the following values: creatine phosphokinase, 1560 U/L (reference range, 52--336 U/L); creatinine, 2.1 mg/dL (0.2--1.0 mg/dL); potassium, 5.3 mEq/L (3.5--5.0 mEq/L); thyroid-stimulating hormone (TSH) 43.2 µIU/mL (0.4--4.8 uIU/mL), free thyroxine (fT4) \<0.3 ng/dL (1.71--2.8  ng/dL) and free triiodothyronine (fT3) 0.48 pg/mL (1.57--4.71 pg/mL). Haematological tests showed haemoglobin 9.4 g/dL  (12--16), white cell count 9000 µL and platelet counts were in normal range. His urine was bloody in appearance and urine analysis showed blood reaction with dipstick test, but no erythrocytes were found on microscopic examination. Fraction excretion of Na and urinary Na were high (2.6% and 46 mEq/L, respectively). Renal tract ultrasonography was normal. No signs suggested the presence of an associated infectious or systemic inflammatory disease. In addition, other causes resulting in rhabdomyolysis such as muscular trauma, drugs and toxins were excluded with history and laboratory investigations. His condition was diagnosed as acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis. This case was also consulted with the department of cardiology physicians who started him on metoprolol 25 mg before beginning thyroid replacement therapy. Cardiac status remained stable: [l-]{.smallcaps}thyroxine 25 microgram/day was prescribed, then 2 weeks later it was continued with [l]{.smallcaps}-thyroxine 50 microgram/day. His fluid deficiency was treated aggressively. His symptoms resolved over the following 3 weeks.

Investigation treatment follow up
=================================

Main laboratory results on admission and during follow up has been showed in [Table 1](#tbl1){ref-type="table"}. Table 1Main laboratory results on admission and during follow-up.**Laboratory investigations0 day3 days7 days14 days**CK (U/L)156067030075Creatinine (mg/dL)2.11.71.30.8LDH (U/L)437--23068AST(U/L)312--16042FT4 (ng/dL)\<0.3----1.2TSH (µIU/mL)43.2----20Thyroxine dose microgram/day25252550[^1]

Discussion
==========

Hypothyroidism can be manifested with muscular symptoms such as myalgia, proximal muscle weakness and cramps. The exact cause of rhabdomyolysis in hypothyroidism has not as yet been fully clarified; the widely accepted hypothesis is that impaired glycogen lysis or impaired mitochondrial oxidative metabolism in hypothyroidism may be responsible for rhabdomyolysis ([@bib1], [@bib2], [@bib3]).

In our case, hypothyroidism was the cause of rhabdomyolysis because of lack of other etiologic agents resulting in rhabdomyolysis. In addition, clinical manifestations have occurred after stopping [l-]{.smallcaps}thyroxine. Moreover, the recovery of clinical symptoms and renal functions after thyroxine replacement therapy supported that and acute renal impairment due to rhabdomyolysis has been induced by hypothyroidism.

The pathophysiology of renal dysfunction in hypothyroidism is not understood thoroughly. Renal impairment with hypothyroidism is thought to be due to reduced cardiac output leading to reduced renal blood and decreased GFR. In addition, T3 showed direct effect on systemic vascular resistance, thus causing renal dysfunction. Furthermore, brain natriuretic peptide levels have correlation with free T3 and T4 levels ([@bib4]). Also, it has been recently shown that T4 is known to regulate Na^+^/Ca^2+^ channels and Na^+^/K^+^-ATPase activity in the sarcoplasmic reticulum of nephrons ([@bib5]). Another important mechanism of renal dysfunction in hypothyroidism is through muscle involvement. Whereas, like in our cases, acute renal impairment due to rhabdomyolysis induced by hypothyroid state is quite rare ([@bib6]).

Prakash *et al*. observed the serum levels of thyroid hormones and CK in hypothyroid patients display inverse ratio. Moreover, serum CK levels can be an important marker for screening the hypothyroid patients ([@bib7]). Also in our cases CK level measured higher than the normal limit.

Most of the previously reported cases of rhabdomyolysis associated with hypothyroidism analysis demonstrated that early aggressive fluid replacement with saline is an important factor in the recovery phase of AKI ([@bib8]). For that reason, we treated fluid deficiency as soon as possible. Therefore, renal functions were fully recovered.

Hypothyroidism can adversely affect the haematological system and lead to the development of anaemia. We noted that the patient had reported having chronic anaemia. After treatment with levothyroxine, the patient's haemoglobin levels returned to normal when followed up 2 months after hospital discharge.

Although hypothyroidism can be accompanied with asymptomatic mild to moderate higher CK level, as far as we know, few previous cases of AKI due to rhabdomyolysis have been associated with hypothyroidism alone ([@bib1]).
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[^1]: CK, creatine kinase (30--135 U/L); AST, aspartate aminotransferase (9--52 U/L); LDH, lactate dehydrogenase (50--245 U/L); FT4, free thyroxine 4 (1.71--2.8 ng/dL); TSH, thyroid-stimulating hormone (0.4--4.8 µIU/mL).
